Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis

Abstract

In a subset of multiple sclerosis (MS) patients antibodies against myelin antigens seem to be important in the demyelinating process. In this study we investigated IgM, IgA and IgG serum antibodies against the myelin oligodendrocyte glycoprotein (MOG) and the myelin basic protein (MBP) in 261 MS patients. Seventy-two per cent had anti-MOG antibodies, 59% were anti-MBP seropositive. The dominating antibody was anti-MOG IgM. A significant relationship between IgA and a progressive disease course was found. The predominance of IgG1 together with the significantly associated occurrence of IgG3 against MOG corresponds to the prevailing IgG1 and IgG3 isotypes in other autoimmune diseases. Patients who actually suffered from a relapse were significant more often anti-MOG and anti-MBP IgG3 seropositive than those in remission. However, patients treated either with intravenous immunoglobulins or interferon-b showed a significant reduction of anti-MOG IgG3 antibodies.

Keywords

immunoglobulin myelin basic protein myelin oligodendrocyte glycoprotein IgG-subclass IgM IgA

Get full access to this article

View all access options for this article.

References

Ozawa K et al. (1994) Patterns of oligodendroglia pathology in multiple sclerosis . Brain 117: 1311-1322 .

Lassmann H , Raine CS , Antel J , Prineas J. (1998) Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna . J Neuroimmunol 86: 213-217 .

Raine CS , Cannella B , Hauser SL , Genain CP. (1999). Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation . Ann Neurol 46: 144-160 .

Storch MK et al. (1998) Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination . Ann Neurol 43: 465-471 .

Lucchinetti C et al. (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination . Ann Neurol 47: 707-717 .

Schluesener HJ , Sobel RA , Linington C , Weiner HL. (1987) A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyeli-nation in central nervous system autoimmune disease . J Immunol 139: 4016-4021 .

Linington C et al. (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein . Am J Pathol 130: 443-454 .

Linington C et al. (1993) T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual auto-immune inflammatory response in the central nervous system . Eur J Immunol 23: 1364-1373 .

Kerlero de Rosbo N , Honegger P , Lassmann H , Matthieu JM. (1990) Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein . J Neurochem 55: 583-587 .

10.

Gardinier MV , Amiguet P , Linington C , Matthieu JM. (1992) Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily . JNeurosci Res 33: 177-187 .

11.

Adelmann M et al. (1995) The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat . J Neuroimmunol 63: 17-27 .

12.

Kroepfl JF et al. (1996) Investigation of myelin/oligodendrocyte glycoprotein membrane topology . J Neurochem 67: 2219-2222 .

13.

Genain CP , Cannella B , Hauser SL , Raine CS. (1999) Identification of autoantibodies associated with myelin damage in multiple sclerosis . Nat Med 5: 170-175 .

14.

Reindl M et al. (1999) Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study . Brain 122: 2047-2056 .

15.

Garcia-Merino A et al. (1986) Serum and cerebrospinal fluid antibodies against myelin basic protein and their IgG subclass distribution in multiple sclerosis . JNeurol Neurosurg Psychiatry 49: 1066-1070 .

16.

Losy J , Michalowska-Wender G , Wender M. (1993) Determination of IgG subclass antibodies to the basic myelin protein in patients with multiple sclerosis . Neurol Neurochir Pol 27: 803-809 .

17.

Bernard CC et al. (1981) Antibody to myelin basic protein in extracts of multiple sclerosis brain . Immunology 43: 447-457 .

18.

Poser CM et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols . Ann Neurol 13: 227-231 .

19.

Lublin FD , Stephen C , Reingold C. (1996) Defining the clinical course of multiple sclerosis . Neurology 46: 907-911 .

20.

Kurtzke JF. (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) . Neurology 33: 1444-1452 .

21.

Wucherpfennig KW , Strominger JL. (1995) Molecular mimicry in T cell mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein . Cell 80: 695-705 .

22.

Linington C , Lassmann H. (1987) Antibody response in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG) . J Neuroimmunol 17: 61-69 .

23.

Genain CP et al. (1995) Antibody facilitation of multiple sclerosis-like lesions in a non human primate . JClin Invest 96: 2966-2974 .

24.

Bernard CC et al. (1997) Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis . J Molec Med 75: 77-88 .

25.

Cruz M et al. (1987) Immunoblot detection of oligoclonal antimyelin basic protein IgG antibodies in cerebrospinal fluid in multiple sclerosis . Neurology 37: 1515-1519 .

26.

Link H. (1997) B cells and autoimmunity. In Russell, WC (ed.). Molecular biology of multiple sclerosis, John Wiley & Sons Ltd., Chichester, UK , pp 161-191.

27.

Lehmann PV , Forsthuber T , Miller A , Sercarz EE. (1992) Spreading of T-cell autoimmunitiy to cryptic determinants of an autoantigen . Nature 358: 155-157 .

28.

Lehmann PV et al. (1993) Determinant spreading and the dynamics of the autoimmune T-cell repertoire . Immunol Today 14: 203-208 .

29.

Vanderlugt CJ , Miller SD. (1996) Epitope spreading . Curr Opin Immunol 8: 831-836 .

30.

Tuohy VK , Yu M , Weinstock Guttman B , Kinkel RP. (1997) Diversity and plasticity of self-recognition during the development of multiple sclerosis . J Clin Invest 99: 1682-1690 .

31.

Walsh MJ , Tourtellotte WW. (1986). Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis . J Exp Med 163: 41-53 .

32.

Kwon EE , Prineas JW. (1994) Blood-brain barrier abnormalities in longstanding multiple sclerosis lesions. An immunohistochemical study . J Neuropathol Exp Neurol 53: 625-636 .

33.

Mestecky J , Russel MW , Jackson S , Brown TA. (1986) The human IgA system: a reassessment . Clin Immunol Immunopathol 40: 105-114 .

34.

McDonnell GV , Hawkins SA. (1996) Primary progressive multiple sclerosis: a distinct syndrome? Mult Scler 2: 137-141 .

35.

Rubin RL et al. (1986) IgG subclasses of antibodies in systemic lupus erythematosus, Sjögren's syndrome, and drug induced autoimmunity . J Immunol 137: 2528-2534 .

36.

Shakib F (1990) The human IgG subclasses: molecular analyses of structure, function and regulation. Pergamon Press, Oxford .

37.

Yount WJ , Cohen P , Eisenberg RA. (1988) Distribution of IgG subclasses among human autoantibodies to Sm, RNP, dsDNA and IgG rheumatoid factor . Monogr Allergy 23: 41-56 .

38.

Gharavi AE et al. (1988) IgG subclass and light chain distribution of anticardiolipin and anti-DNA antibodies in SLE . Ann Rheum Dis 47: 286-290 .

39.

Piddlesden SJ et al. (1993) The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement . Am J Pathol 143: 555-564 .

40.

Kozovska ME et al. (1999) Interferon beta induces T-helper 2 immune deviation in MS . Neurology 53: 1692-1697 .